Piperidin-4-ol → Quinoxaline-5-sulfonic acid [2-(4-hydroxy-piperidine-1-carbonyl)-5-bromo-phenyl]-amide

반응식

[Br:1][c:2]1[cH:3][c:4]([NH:11][S:12](=[O:13])(=[O:14])[c:15]2[c:16]3[n:17][cH:18][cH:19][n:20][c:21]3[cH:22][cH:23][cH:24]2)[c:5]([C:6](=[O:7])[OH:8])[cH:9][cH:10]1.[OH:25][CH:26]1[CH2:27][CH2:28][NH:29][CH2:30][CH2:31]1>>[Br:1][c:2]1[cH:3][c:4]([NH:11][S:12](=[O:13])(=[O:14])[c:15]2[c:16]3[n:17][cH:18][cH:19][n:20][c:21]3[cH:22][cH:23][cH:24]2)[c:5]([C:6](=[O:7])[N:29]2[CH2:28][CH2:27][CH:26]([OH:25])[CH2:31][CH2:30]2)[cH:9][cH:10]1

참가 물질

반응물 2

HCID 79341Piperidin-4-ol

HCID 114297084-Bromo-2-(quinoxaline-5-sulfonylamino)benzoic acid

생성물 1

HCID 11306408Quinoxaline-5-sulfonic acid [2-(4-hydroxy-piperidine-1-carbonyl)-5-bromo-phenyl]-amide

출처 및 근거

ORD 기록: ord-509342b6fd354e6b8e776f3ea28749eb
출처 데이터셋: Test data from https://doi.org/10.1039/C8SC04228D
DOI: 10.1039/C8SC04228D

반응 노트

불러오는 중…